Cynata Therapeutics: A big tick from the American Food and Drug Administration

Listen to ASX-listed Cynata Therapeutics Managing Director Ross Macdonald talk to Matt Birney on the Bulls N’ Bears Report about Cynata’s upcoming clinical trial of its remarkable stem cell related therapies that has been green-lighted by the American FDA. 

Cynata Therapeutics: A big tick from the American Food and Drug Administration
Listen to ASX-listed Cynata Therapeutics Managing Director Ross Macdonald talk to Matt Birney on the Bulls N&rsquo; Bears Report about Cynata&rsquo;s upcoming clinical trial of its remarkable stem cell related therapies that has been green-lighted by the American FDA.&nbsp;

Matt Birney and Bulls N' Bears sit at the epicentre of the small cap ASX-listed company space in Perth and Western Australia. Bulls N’ Bears covers public company news, views and CEO interviews across a number of main stream media platforms in WA. Its financial markets followers, who come from all four corners of the globe, are looking to zero in on Western Australia’s unique international status as the most prolific developer of small capped publicly listed companies in the world.

Matt Birney and Bulls N' Bears sit at the epicentre of the small cap ASX-listed company space in Perth and Western Australia. Bulls N&rsquo; Bears covers public company news, views and CEO interviews across a number of main stream media platforms in WA. Its financial markets followers, who come from all four corners of the globe, are looking to zero in on Western Australia&rsquo;s unique international status as the most prolific developer of small capped publicly listed companies in the world.

Advertisement